Literature DB >> 25493330

Size unbiased representative enzymatically generated RNAi (SURER) library and application for RNAi therapeutic screens.

Tiejun Li1, York Yuanyuan Zhu, Li Chen, Yuncheng Sun, Jian Yuan, Michael Graham, Peter French.   

Abstract

RNA interference (RNAi) libraries screens have become widely used for small RNA (sRNA) therapeutic targets development. However, conventional enzymatically libraries, typically prepared using the type 2 restriction enzyme MmeI, produce sRNAs between 18 and 20 bp, much shorter than the usual lengths of 19-23 bp. Here we develop a size unbiased representative enzymatically generated RNAi (SURER) library, which employs type 3 restriction modification enzyme EcoP15I to produce sRNAs ranging from 19 to 23 bp using a group of rationally designed linkers, which can completely mimic the length of sRNAs naturally generated by Dicer enzyme in living cells, and the screening results of SURER libraries showed high recombination rate and knockdown efficiency. SURER library provides a useful tool for RNAi therapeutics screening in a fast and simple way.

Mesh:

Substances:

Year:  2014        PMID: 25493330      PMCID: PMC4296746          DOI: 10.1089/nat.2014.0514

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  43 in total

Review 1.  Enzymatically prepared RNAi libraries.

Authors:  Frank Buchholz; Ralf Kittler; Mikolaj Slabicki; Mirko Theis
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

2.  Activating gene expression in mammalian cells with promoter-targeted duplex RNAs.

Authors:  Bethany A Janowski; Scott T Younger; Daniel B Hardy; Rosalyn Ram; Kenneth E Huffman; David R Corey
Journal:  Nat Chem Biol       Date:  2007-01-28       Impact factor: 15.040

Review 3.  MicroRNAs in disease and potential therapeutic applications.

Authors:  Harris S Soifer; John J Rossi; Pål Saetrom
Journal:  Mol Ther       Date:  2007-09-18       Impact factor: 11.454

4.  DNA-dependent DNA polymerases.

Authors:  S Tabor; K Struhl; S J Scharf; D H Gelfand
Journal:  Curr Protoc Mol Biol       Date:  2001-05

5.  Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes.

Authors:  Toshiaki Watanabe; Yasushi Totoki; Atsushi Toyoda; Masahiro Kaneda; Satomi Kuramochi-Miyagawa; Yayoi Obata; Hatsune Chiba; Yuji Kohara; Tomohiro Kono; Toru Nakano; M Azim Surani; Yoshiyuki Sakaki; Hiroyuki Sasaki
Journal:  Nature       Date:  2008-04-10       Impact factor: 49.962

Review 6.  Development of RNA interference-based therapeutics and application of multi-target small interfering RNAs.

Authors:  Tiejun Li; Meihua Wu; York Yuanyuan Zhu; Jianxin Chen; Li Chen
Journal:  Nucleic Acid Ther       Date:  2014-05-05       Impact factor: 5.486

7.  Small dsRNAs induce transcriptional activation in human cells.

Authors:  Long-Cheng Li; Steven T Okino; Hong Zhao; Deepa Pookot; Robert F Place; Shinji Urakami; Hideki Enokida; Rajvir Dahiya
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

8.  In vitro reconstitution of the human RISC-loading complex.

Authors:  Ian J MacRae; Enbo Ma; Min Zhou; Carol V Robinson; Jennifer A Doudna
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

Review 9.  Endogenous small interfering RNAs in animals.

Authors:  Katsutomo Okamura; Eric C Lai
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

10.  DSIR: assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes.

Authors:  Odile Filhol; Delphine Ciais; Christian Lajaunie; Peggy Charbonnier; Nicolas Foveau; Jean-Philippe Vert; Yves Vandenbrouck
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

View more
  1 in total

1.  Expression and function of tetraspanin 1 in esophageal carcinoma.

Authors:  Tingting Gu; Weiwei Chen; Li Chen; Guilan Wang; Tiejun Li; Yuanyuan Zhu; Xiaojiao Gao
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.